-
-
-
-
-
-
-
Gilead Sciences Announces First Quarter Financial Results
-
-
-
-
-
-
-
PEPFAR and Global Fund expand lenacapavir access to 1 million more people
-
-
-
-
-
-
-
Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline
-
-
-
-
-
-
-
Gilead to buy Ouro Medicines for up to $2.2 billion
-
-
-
-
-
-
-
Bernstein on Gilead Sciences (GILD) Post Arcellx Acquisition: 'We Like This Deal'
-
-
-
-
-
-
-
Gilead Sciences acquires Repare drug candidate for up to $30 million
-
-
-
-
-
-
-
Gilead Joins Partners for Delivery of First Shipments of Breakthrough Twice-yearly Lenacapavir for HIV Prevention to Sub-Saharan Africa
-
1,160,146 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

